JOHNSON & JOHNSON (JNJ) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:JNJ - US4781601046 - Common Stock
211.58 USD
+1.57 (+0.75%)
211.72 USD
+0.14 (+0.07%)
ChartMill assigns a Buy % Consensus number of 76% to JNJ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 206.71. This target is -2.3% below the current price.
JNJ was analyzed by 32 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about JNJ.
In the previous month the buy percentage consensus was at a similar level.
JNJ was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-05 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-22 | Freedom Capital Markets | Downgrade | Buy -> Hold |
| 2025-10-15 | Stifel | Maintains | Hold -> Hold |
| 2025-10-15 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-15 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-14 | UBS | Maintains | Buy -> Buy |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-06 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2025-10-03 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-03 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-23 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-09-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-17 | Guggenheim | Maintains | Neutral -> Neutral |
| 2025-07-17 | UBS | Maintains | Buy -> Buy |
| 2025-07-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-17 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-17 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-07-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-13 | Leerink Partners | Downgrade | Outperform -> Market Perform |
JOHNSON & JOHNSON / JNJ FAQ
Can you provide the average price target for JOHNSON & JOHNSON stock?
32 analysts have analysed JNJ and the average price target is 206.71 USD. This implies a price decrease of -2.3% is expected in the next year compared to the current price of 211.58.
Can you provide the consensus rating for JOHNSON & JOHNSON stock?
The consensus rating for JOHNSON & JOHNSON (JNJ) is 75.625 / 100 . This indicates that analysts generally have a positive outlook on the stock.